Status:
RECRUITING
Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool
Lead Sponsor:
OHSU Knight Cancer Institute
Collaborating Sponsors:
Oregon Health and Science University
American Cancer Society, Inc.
Conditions:
Lung Carcinoma
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is...
Detailed Description
PRIMARY OBJECTIVES: I. Conduct a randomized, controlled trial evaluating the efficacy of a conversation tool on patient-centered health and decision-making outcomes among patients making lung cancer ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- AIM 1: Suspected lung cancer
- AIM 1: English fluency
- AIM 1: \> 6-month life expectancy
- AIM 1: Score of ≥ 3 on the cognitive impairment screener
- AIM 2 PARTICIPANTS: Participation in Aim 1
- AIM 2 CLINICIANS: Discussing lung cancer treatment decisions with Aim 1 participants
Exclusion
Key Trial Info
Start Date :
October 31 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05407168
Start Date
October 31 2022
End Date
December 31 2027
Last Update
April 9 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Hillsboro Medical Center
Hillsboro, Oregon, United States, 97123
2
Adventist Health Portland
Portland, Oregon, United States, 97216
3
OHSU Knight Cancer Institute
Portland, Oregon, United States, 97239
4
Portland VA Medical Center
Portland, Oregon, United States, 97239